BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38778816)

  • 21. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
    De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
    Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer.
    Zeng H; Hou Y; Zhou X; Lang L; Luo H; Sun Y; Wan X; Yuan T; Wang R; Liu Y; Tang R; Cheng S; Xu M; Liu M
    Theranostics; 2022; 12(17):7351-7370. PubMed ID: 36438499
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment.
    Zhang J; Song C; Tian Y; Yang X
    Front Immunol; 2021; 12():802080. PubMed ID: 35126365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
    Chen S; Giannakou A; Wyman S; Gruzas J; Golas J; Zhong W; Loreth C; Sridharan L; Yamin TT; Damelin M; Geles KG
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11671-E11680. PubMed ID: 30487219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts.
    Kong J; Tian H; Zhang F; Zhang Z; Li J; Liu X; Li X; Liu J; Li X; Jin D; Yang X; Sun B; Guo T; Luo Y; Lu Y; Lin B; Liu T
    Mol Cancer; 2019 Dec; 18(1):175. PubMed ID: 31796058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma.
    Pan X; Zhou J; Xiao Q; Fujiwara K; Zhang M; Mo G; Gong W; Zheng L
    J Hematol Oncol; 2021 Nov; 14(1):184. PubMed ID: 34727952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
    Peng Z; Ye M; Ding H; Feng Z; Hu K
    J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling.
    Zhou Z; Cui D; Sun MH; Huang JL; Deng Z; Han BM; Sun XW; Xia SJ; Sun F; Shi F
    FASEB J; 2020 Jun; 34(6):7970-7988. PubMed ID: 32293074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis.
    Jiang Y; Wang K; Lu X; Wang Y; Chen J
    Mol Immunol; 2021 Dec; 140():47-58. PubMed ID: 34653794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling.
    Kugeratski FG; Atkinson SJ; Neilson LJ; Lilla S; Knight JRP; Serneels J; Juin A; Ismail S; Bryant DM; Markert EK; Machesky LM; Mazzone M; Sansom OJ; Zanivan S
    Sci Signal; 2019 Feb; 12(567):. PubMed ID: 30723174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer.
    Aizawa T; Karasawa H; Funayama R; Shirota M; Suzuki T; Maeda S; Suzuki H; Yamamura A; Naitoh T; Nakayama K; Unno M
    Cancer Med; 2019 Oct; 8(14):6370-6382. PubMed ID: 31468733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
    Suzuki J; Tsuboi M; Ishii G
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice.
    Yu L; Hales CA
    BMC Cancer; 2011 Aug; 11():331. PubMed ID: 21812995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
    Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
    Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling.
    Tang X; Hou Y; Yang G; Wang X; Tang S; Du YE; Yang L; Yu T; Zhang H; Zhou M; Wen S; Xu L; Liu M
    Cell Death Differ; 2016 Jan; 23(1):132-45. PubMed ID: 26068592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.
    Deng S; Cheng D; Wang J; Gu J; Xue Y; Jiang Z; Qin L; Mao F; Cao Y; Cai K
    J Exp Clin Cancer Res; 2023 Nov; 42(1):294. PubMed ID: 37926835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.